Page last updated: 2024-10-22

amsacrine and Mesothelioma

amsacrine has been researched along with Mesothelioma in 1 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Mesothelioma: A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Falkson, G1
Vorobiof, DA1
Lerner, HJ1

Other Studies

1 other study available for amsacrine and Mesothelioma

ArticleYear
A phase II study of m-AMSA in patients with malignant mesothelioma.
    Cancer chemotherapy and pharmacology, 1983, Volume: 11, Issue:2

    Topics: Abdominal Neoplasms; Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Agents; Drug Evaluation;

1983